Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 31 AL 45

Inhibition of double-stranded RNA-dependent protein kinase strongly decreases cytokine production and release in peripheral blood mononuclear cells from patients with Alzheimer's disease

Couturier J, Page G, Morel M, Gontier C, Claude J, Pontcharraud R, Fauconneau B, Paccalin M.

J Alzheimers Dis. 2010;21(4):1217-31. doi: 10.3233/jad-2010-100258.

Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?

Trepanier CH, Milgram NW.

J Alzheimers Dis. 2010;21(4):1089-99. doi: 10.3233/jad-2010-090667.

Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease

Dang TN, Arseneault M, Zarkovic N, Waeg G, Ramassamy C.

J Alzheimers Dis. 2010;21(4):1197-216. doi: 10.3233/jad-2010-100417.

Dementia

Warner JP, Butler R, Gupta S.

BMJ Clin Evid. 2010 Apr 8;2010:1001.

Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease

Fu AL, Zhou CY, Chen X.

Neuropharmacology. 2010 Mar-Apr;58(4-5):722-9. doi: 10.1016/j.neuropharm.2009.12.020. Epub 2010 Jan 5.

Naturally occurring phytochemicals for the prevention of Alzheimer's disease

Kim J, Lee HJ, Lee KW.

J Neurochem. 2010 Mar;112(6):1415-30. doi: 10.1111/j.1471-4159.2009.06562.x. Epub 2009 Dec 26.

Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence

Albani D, Polito L, Forloni G.

J Alzheimers Dis. 2010;19(1):11-26. doi: 10.3233/JAD-2010-1215.

Why vitamin E therapy fails for treatment of Alzheimer's disease

Brewer GJ.

J Alzheimers Dis. 2010;19(1):27-30. doi: 10.3233/JAD-2010-1238.

Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease

Wang L, Harms MP, Staggs JM, Xiong C, Morris JC, Csernansky JG, Galvin JE.

Arch Neurol. 2010 Jan;67(1):99-106. doi: 10.1001/archneurol.2009.292.

Virus-like peptide vaccines against Abeta N-terminal or C-terminal domains reduce amyloid deposition in APP transgenic mice without addition of adjuvant

Li QY, Gordon MN, Chackerian B, Alamed J, Ugen KE, Morgan D.

J Neuroimmune Pharmacol. 2010 Mar;5(1):133-42. doi: 10.1007/s11481-009-9183-1.

Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch

Sadowsky C, Perez JA, Bouchard RW, Goodman I, Tekin S.

CNS Neurosci Ther. 2010 Spring;16(1):51-60. doi: 10.1111/j.1755-5949.2009.00119.x.

[Alzheimer's disease, cerebral blood flow, and nitric oxide]

Toda N, Ayajiki K.

Nihon Yakurigaku Zasshi. 2010 Jan;135(1):20-4. doi: 10.1254/fpj.135.20.

Quantitative pharmacology approach in Alzheimer's disease: efficacy modeling of early clinical data to predict clinical outcome of tesofensine

Lehr T, Staab A, Trommeshauser D, Schaefer HG, Kloft C.

AAPS J. 2010 Jun;12(2):117-29. doi: 10.1208/s12248-009-9164-6. Epub 2010 Jan 15.

The dysregulation of intracellular calcium in Alzheimer disease

Supnet C, Bezprozvanny I.

Cell Calcium. 2010 Feb;47(2):183-9. doi: 10.1016/j.ceca.2009.12.014. Epub 2010 Jan 18.

Sertraline for the treatment of depression in Alzheimer disease

Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Feb;18(2):136-45. doi: 10.1097/JGP.0b013e3181c796eb.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias